Beta-PRESERVE Study

Have you recently been diagnosed with (Stage 3) Type 1 diabetes?

A study to investigate the efficacy and safety of teplizumab compared with placebo  in participants  aged 1 to 25 years of age with recently diagnosed stage 3 type 1 diabetes (T1D)

Status: Open to recruitment.

To join this research study, you must:

• Be aged 1 to 25
• Recently diagnosed with stage 3 type 1 diabetes

Location: Cambridge Clinical Research Centre on Keith Day Road, next to the Addenbrooke’s Treatment Centre, and part of the Cambridge Biomedical Centre.

Find out more
Email: Jane Kennet